K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

被引:254
|
作者
Brink, M
de Goeij, AFPM
Weijenberg, MP
Roemen, GMJM
Lentjes, MHFM
Pachen, MMM
Smits, KM
de Bruïne, AP
Goldbohm, RA
van den Brandt, PA
机构
[1] Maastrict Univ, Dept Epidemiol, NUTRIM, NL-6200 MD Maastricht, Netherlands
[2] Maastrict Univ, Dept Pathol, GROW, Maastricht, Netherlands
[3] TNO Nutr & Food Res, NL-3700 AJ Zeist, Netherlands
关键词
D O I
10.1093/carcin/bgg009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30-60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55-69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be mutated. The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 50 条
  • [11] Mutations in APC, CTNNBI and K-ras genes and expression of hMLHI in sporadic colorectal carcinomas from the Netherlands Cohort Study -: art. no. 160
    Lüchtenborg, M
    Weijenberg, MP
    Wark, PA
    Saritas, AM
    Roemen, GMJM
    van Muijen, GNP
    de Bruïne, AP
    van den Brandt, PA
    de Goeij, AFPM
    BMC CANCER, 2005, 5 (1)
  • [12] Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study
    Margreet Lüchtenborg
    Matty P Weijenberg
    Petra A Wark
    A Merdan Saritas
    Guido MJM Roemen
    Goos NP van Muijen
    Adriaan P de Bruïne
    Piet A van den Brandt
    Anton FPM de Goeij
    BMC Cancer, 5
  • [13] Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort
    Levi M.
    Prayogi G.
    Sastranagara F.
    Sudianto E.
    Widjajahakim G.
    Gani W.
    Mahanadi A.
    Agnes J.
    Khairunisa B.H.
    Utomo A.R.
    Journal of Gastrointestinal Cancer, 2018, 49 (2) : 124 - 131
  • [14] K-ras Mutations in the Plasma of Colorectal Cancer Patients
    Shen, Yong-qi
    Ye, Yun-bin
    Zheng, Xiong-wei
    Li, Chao
    Chen, Qiang
    LABMEDICINE, 2010, 41 (03): : 156 - 158
  • [15] K-RAS gene mutations and susceptibility to colorectal cancer
    Prasad, S. S.
    Sekaran, A.
    Rao, G. V.
    Rebala, P.
    Tandan, M.
    Kaitha, A.
    Reddy, D. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 221 - 222
  • [16] Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma
    Bockhorn, M
    Frilling, A
    Kalinin, V
    Schröder, S
    Broelsch, CE
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (01) : 49 - 53
  • [17] Ethnic difference in the pattern of K-ras oncogene mutations in human colorectal cancers
    Hayashi, N
    Sugai, S
    Ito, I
    Nakamori, S
    Ogawa, M
    Nakamura, Y
    HUMAN MUTATION, 1996, 8 (03) : 258 - 261
  • [18] DETECTION OF POINT MUTATIONS IN K-RAS ONCOGENE IN LUNG-CANCER
    HACKMAN, P
    HUSGAFVELPURSIAINEN, K
    ANTTILA, S
    RIDANPAA, M
    KARJALAINEN, A
    HEIKKILA, L
    VAINIO, H
    MUTATION RESEARCH, 1991, 252 (02): : 203 - 203
  • [19] K-RAS ONCOGENE CODON 12 POINT MUTATIONS IN TESTICULAR CANCER
    RIDANPAA, M
    LOTHE, RA
    ONFELT, A
    FOSSA, S
    BORRESEN, AL
    HUSGAFVELPURSIAINEN, K
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 : 185 - 187
  • [20] The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer
    Pajkos, G
    Kiss, I
    Sándor, J
    Ember, I
    Kisházi, P
    ANTICANCER RESEARCH, 2000, 20 (3A) : 1695 - 1701